Clinical Evaluation of BioPlex 2200 HIV Ag-Ab, an Automated Screening Method Providing Discrete Detection of HIV-1 p24 Antigen, HIV-1 Antibody, and HIV-2 Antibody

Journal of Clinical Microbiology

Volumn 52, Issue 1, 2014, Pages 103-107

  Salmona, Maud ^a   Delarue, Severine ^a   Delaugerre, Constance ^a,b   Simon, François ^a,b   Maylin, Sarah ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS 1 P24 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS 2 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARCHITECT HIV COMBO ASSAY; ARTICLE; ASSAY; AUTOMATION; BIOPLEX 2200 ASSAY; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FALSE POSITIVE RESULT; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AUTOMATION, LABORATORY; CLINICAL LABORATORY TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MASS SCREENING; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84891518471     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02460-13     Document Type: Article

References (21)

1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR, HPTN 052 Study Team. 2011. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365: 493-505. http://dx.doi.org/10.1056/NEJMoa1105243.
2. Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, Dewar R, Marovich M, van Griensven F, Sekaly R, Pinyakorn S, Phanuphak N, Trichavaroj R, Rutvisuttinunt W, Chomchey N, Paris R, Peel S, Valcour V, Maldarelli F, Chomont N, Michael N, Phanuphak P, Kim JH, RV254/SEARCH 010 Study Group. 2012. Impact of multitargeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 7:e33948. http://dx.doi.org/10.1371/journal.pone.0033948.
3. Sáez-Cirión A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, Potard V, Versmisse P, Melard A, Prazuck T, Descours B, Guergnon J, Viard J-P, Boufassa F, Lambotte O, Goujard C, Meyer L, Costagliola D, Venet A, Pancino G, Autran B, Rouzioux C, Study Group ANRS VISCONTI. 2013. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. Plos Pathog. 9:e1003211. http://dx.doi.org/10.1371/journal.ppat.1003211.
4. Weber B, Orazi B, Raineri A, Thorstensson R, Bürgisser P, Mühlbacher A, Areal C, Eiras A, Villaescusa R, Camacho R, Diogo I, Roth HJ, Zahn I, Bartel J, Bossi V, Piro F, Atamasirikul K, Permpikul P, Webber L, Singh S. 2006. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clin. Lab. 52:463-473. http://dx.doi.org/10.1007/s00430-012- 0250-5.
5. Weber B, Fall EH, Berger A, Doerr HW. 1998. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J. Clin. Microbiol. 36:2235-2239.
6. Malm K, von Sydow M, Andersson S. 2009. Performance of three automated fourth-generation combined HIV antigen/antibody assays in largescale screening of blood donors and clinical samples. Transfus. Med. Oxf. Engl. 19:78-88. http://dx.doi.org/10.1111/j.1365-3148.2009.00907.x.
7. Gürtler L, Mühlbacher A, Michl U, Hofmann H, Paggi GG, Bossi V, Thorstensson R, G-Villaescusa R, Eiras A, Hernandez JM, Melchior W, Donie F, Weber B. 1998. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J. Virol. Methods 75:27-38. http://dx.doi.org/10.1016/S0166-0934(98)00094-9.
8. Ly TD, Martin L, Daghfal D, Sandridge A, West D, Bristow R, Chalouas L, Qiu X, Lou SC, Hunt JC, Schochetman G, Devare SG. 2001. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: Evaluation of HIV seroconversion sensitivity and subtype detection. J. Clin. Microbiol. 39:3122-3128. http://dx.doi.org/10.1128/JCM.39.9 .3122-3128.2001.
9. Brust S, Duttmann H, Feldner J, Gürtler L, Thorstensson R, Simon F. 2000. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. J. Virol. Methods 90:153-165. http://dx.doi.org/10.1016/S0166-0934(00)00229-9.
10. Saville RD, Constantine NT, Cleghorn FR, Jack N, Bartholomew C, Edwards J, Gomez P, Blattner WA. 2001. Fourth-generation enzymelinked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody. J. Clin. Microbiol. 39: 2518-2524. http://dx.doi.org/10.1128/JCM.39. 7.2518-2524.2001.
11. Van Binsbergen J, Siebelink A, Jacobs A, Keur W, Bruynis F, van de Graaf M, van der Heijden J, Kambel D, Toonen J. 1999. Improved performance of seroconversion with a 4th generation HIV antigen/antibody assay. J. Virol. Methods 82:77-84. http://dx.doi.org/10.1016/S0166-0934(99)00086-5.
12. Van Binsbergen J, Keur W, Siebelink A, van de Graaf M, Jacobs A, de Rijk D, Nijholt L, Toonen J, Gürtler LG. 1998. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: A new generation Vironostika HIV Uni-Form II. J. Virol. Methods 76:59-71. http://dx.doi.org/10.1016/S0166-0934(98)00126-8.
13. Chiara M, Rony Z, Homa M, Bhanumati V, Ladomirska J, Manzi M, Wilson N, Alaka D, Harries AD. 2010. Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai. Indian J. Med. Res. 132:683-689.
14. Damond F, Brun-Vezinet F, Matheron S, Peytavin G, Campa P, Pueyo S, Mammano F, Lastere S, Farfara I, Simon F, Chene G, Descamps D. 2005. Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors. J. Clin. Microbiol. 43:484-487. http://dx.doi.org/10. 1128/JCM.43.1.484-487.2005.
15. Reeves JD, Doms RW. 2002. Human immunodeficiency virus type 2. J. Gen. Virol. 83:1253-1265.
16. Roques P, Robertson DL, Souquière S, Damond F, Ayouba A, Farfara I, Depienne C, Nerrienet E, Dormont D, Brun-Vézinet F, Simon F, Mauclère P. 2002. Phylogenetic analysis of 49 newly derived HIV-1 group O strains: High viral diversity but no group M-like subtype structure. Virology 302:259-273. http://dx.doi.org/10.1006/viro.2002.1430.
17. Depatureaux A, Leoz M, De Oliveira F, Gueudin M, Damond F, Descamps D, Brun-Vézinet F, Lemée V, Simon F, Barin F, Plantier J-C. 2010. Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data. Med. Mal. Infect. 40:669-676. (In French.) http://dx.doi.org/10.1016/j.medmal.2010. 04.011.
18. Gueudin M, Plantier JC, Lemée V, Schmitt MP, Chartier L, Bourlet T, Ruffault A, Damond F, Vray M, Simon F. 2007. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44:500-505. http://dx.doi.org/10.1097/QAI. 0b013e31803260df.
19. Plantier J-C, Djemai M, Lemée V, Reggiani A, Leoz M, Burc L, Vessière A, Rousset D, Poveda J-D, Henquell C, Gautheret-Dejean A, Barin F. 2009. Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 groupOinfections. J. Clin. Microbiol. 47:2906-2911. http://dx.doi.org/10.1128/JCM.00602-09.
20. Damond F, Collin G, Descamps D, Matheron S, Pueyo S, Taieb A, Campa P, Benard A, Chêne G, Brun-Vezinet F. 2005. Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J. Clin. Microbiol. 43:4234-4236. http://dx.doi.org/10.1128/JCM.43.8.4234-4236.2005.
21. Gaudy C, Moreau A, Brunet S, Descamps J-M, Deleplanque P, Brand D, Barin F. 2004. Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection. J. Clin. Microbiol. 42:2847-2849. http://dx.doi.org/10.1128/JCM.42.6.2847-2849.2004.